ATE323495T1 - Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer - Google Patents

Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer

Info

Publication number
ATE323495T1
ATE323495T1 AT98957031T AT98957031T ATE323495T1 AT E323495 T1 ATE323495 T1 AT E323495T1 AT 98957031 T AT98957031 T AT 98957031T AT 98957031 T AT98957031 T AT 98957031T AT E323495 T1 ATE323495 T1 AT E323495T1
Authority
AT
Austria
Prior art keywords
sulfamat
estron
steroid
derivatives
sulfatase inhibitors
Prior art date
Application number
AT98957031T
Other languages
English (en)
Inventor
Michael John Reed
Barry Victor Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ATE323495T1 publication Critical patent/ATE323495T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016Oximes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT98957031T 1997-12-04 1998-12-03 Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer ATE323495T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9725750A GB2331988B (en) 1997-12-04 1997-12-04 Polycyclic sulphamate inhibitors or oestrone sulphatase

Publications (1)

Publication Number Publication Date
ATE323495T1 true ATE323495T1 (de) 2006-05-15

Family

ID=10823156

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98957031T ATE323495T1 (de) 1997-12-04 1998-12-03 Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer

Country Status (10)

Country Link
US (2) US6949561B1 (de)
EP (1) EP1051177B1 (de)
JP (1) JP3820349B2 (de)
AT (1) ATE323495T1 (de)
AU (1) AU1345699A (de)
DE (1) DE69834271T2 (de)
DK (1) DK1051177T3 (de)
ES (1) ES2260856T3 (de)
GB (2) GB2331988B (de)
WO (1) WO1999027935A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
AU765386B2 (en) 1998-06-10 2003-09-18 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-(o)-sulphamate for inhibition of estrone sulphatase
US20080015174A1 (en) * 1998-11-24 2008-01-17 Reading Christopher L Metabolic Disease Treatments
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
NZ515061A (en) * 1999-04-30 2004-04-30 Sterix Ltd Use of a cyclic compound in cell cycling
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
CO5261573A1 (es) 1999-11-19 2003-03-31 Novartis Ag Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
AU2001248849A1 (en) 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
DE10307103A1 (de) 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
US10030478B2 (en) 2014-05-20 2018-07-24 Baker Hughes, A Ge Company, Llc Mechanically actuated variable choke system for subterranean use
CN104311621B (zh) * 2014-11-18 2016-05-11 郑州大学 D环修饰的甾体β-内酰胺类化合物、其制备方法及其应用
WO2016084790A1 (ja) * 2014-11-25 2016-06-02 第一三共株式会社 ヒドロナフトキノリン誘導体

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2324592A1 (de) * 1973-05-16 1974-12-05 Basf Ag Substituierte benzofuranylester
DE2402370A1 (de) * 1974-01-18 1975-07-31 Basf Ag Substituierte benzofuranylester
US4155918A (en) 1976-10-28 1979-05-22 Hoffmann-La Roche Inc. Novel D-homosteroids
HU175287B (hu) * 1977-08-18 1980-06-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh 3-amino-17al'fa-aza-d-gomo-androstana,dalee ikh kislotoaddicionnykh i chetvjortichnykh solej
DE2755578A1 (de) 1977-12-09 1979-06-13 Schering Ag C-homo-oestratriene
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
WO1985005361A1 (en) 1984-05-21 1985-12-05 Sri International 17abeta-HYDROXY-7alpha-METHYL-D-HOMO-19-NORANDROST-4,16-DIENE-3-ONE AND THE 17-ESTERS THEREOF: METHODS OF PREPARATION AND USES
US4874891A (en) 1986-05-01 1989-10-17 Washington University Open "D" ring hormone analogs
PT94305B (pt) * 1989-06-12 1997-02-28 Robins Co Inc A H Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9603325D0 (en) 1996-02-16 1996-04-17 Imperial College A compound
GB9118478D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
JP2746041B2 (ja) 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体
US5260299A (en) 1992-03-05 1993-11-09 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents
JPH08502721A (ja) 1992-04-03 1996-03-26 ジ・アップジョン・カンパニー 医薬的に活性な二環式‐複素環アミン
WO1997005126A1 (en) 1995-07-29 1997-02-13 Smithkline Beecham Plc Mupirocinsulfamates with antibacterial activity
ES2233998T3 (es) 1996-03-05 2005-06-16 Sterix Limited Compuestos que comprenden un grupo sulfamato.
CN1131238C (zh) * 1996-09-12 2003-12-17 帝国脏器制药株式会社 3-取代-d-高-1,3,5(10)-雌三烯衍生物
DE19712488A1 (de) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same

Also Published As

Publication number Publication date
GB2380939A (en) 2003-04-23
GB0227655D0 (en) 2003-01-08
WO1999027935A1 (en) 1999-06-10
GB2380939B (en) 2003-09-10
GB9725750D0 (en) 1998-02-04
EP1051177B1 (de) 2006-04-19
US20050124643A1 (en) 2005-06-09
GB2331988B (en) 2003-04-16
DK1051177T3 (da) 2006-07-24
ES2260856T3 (es) 2006-11-01
EP1051177A1 (de) 2000-11-15
DE69834271D1 (de) 2006-05-24
US6949561B1 (en) 2005-09-27
JP3820349B2 (ja) 2006-09-13
DE69834271T2 (de) 2006-10-19
AU1345699A (en) 1999-06-16
GB2331988A (en) 1999-06-09
GB2331988A9 (en)
JP2001524524A (ja) 2001-12-04

Similar Documents

Publication Publication Date Title
ATE323495T1 (de) Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
DE69733061D1 (de) Nicht-steroidale polyzyklische sulfamat-derivate, deren herstellung und deren verwendung als östron sulfatase inhibitoren
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
ATE451107T1 (de) 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
ATE195530T1 (de) 17-ether und thioether von 4-aza-steroiden
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
DE69516866D1 (de) Stereochemische wortmanninderivate
ATE326448T1 (de) Arylpiperazin-derivate und ihre verwendung als metalloproteinase hemmende wirkstoffe (mmp)
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
MX9204522A (es) Derivados 4-benzoil-isoxazol, procedimiento para su preparacion y composicion herbicida que los contiene.
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
DK0544821T3 (da) Indolderivater som antiallergiske og antiinflammatoriske midler
EA199800484A1 (ru) Лактоновые производные 17.бета.-карбокси, карботио и амид андростанов
ATE411335T1 (de) Östrogen-sulfamate als sulfataseinhibitoren
DK279790A (da) Aromatiske steroid-5-alfa-reduktaseinhibitorer
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
BR9706902A (pt) Uso de pelo menos um inibidor da atividade do ácido retinóico e composição
NZ330244A (en) Isoxazole derivatives useful in the treatment of inflammatory diseases
ATE320422T1 (de) Metalloproteinase inhibitoren
PA8495001A1 (es) Nuevas formas cristalinas de un antibiotico macrolido.
MXPA00012177A (es) Derivados de hiperforina, uso de los mismos y formulaciones que los contienen.
ES2059779T3 (es) Compuestos anti-androgenos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1051177

Country of ref document: EP